Literature DB >> 3593625

Reduction of metformin renal tubular secretion by cimetidine in man.

A Somogyi, C Stockley, J Keal, P Rolan, F Bochner.   

Abstract

To determine whether cimetidine altered the renal handling of metformin, seven subjects took 0.25 g metformin daily with and without cimetidine 0.4 g twice daily. Blood and urine samples were collected and assayed for metformin, cimetidine and creatinine by h.p.l.c. Cimetidine significantly increased the area under the plasma metformin concentration-time curve by an average of 50% and reduced its renal clearance over 24 h by 27% (P less than 0.008). There was no alteration in the total urinary recovery of metformin when cimetidine was co-administered. The effect of cimetidine on the renal clearance of metformin was time dependent, being significantly reduced up to 6 h following cimetidine. These results appeared to be consistent with competitive inhibition of renal tubular secretion. Cimetidine had no effect on the renal clearance of creatinine, but time-dependent variations in both metformin and creatinine renal clearance were observed. Metformin had no effect on cimetidine disposition. It is concluded that cimetidine inhibits the renal tubular secretion of metformin in man, resulting in higher circulating plasma concentrations. Because of its propensity for causing dose and concentration-dependent adverse effects, the dose of metformin should be reduced when cimetidine is co-prescribed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593625      PMCID: PMC1386190          DOI: 10.1111/j.1365-2125.1987.tb03090.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Diurnal variations of renal function in man.

Authors:  J H SIROTA; D S BALDWIN; H VILLARREAL
Journal:  J Clin Invest       Date:  1950-02       Impact factor: 14.808

2.  Rapid and sensitive high-performance liquid chromatographic assay for metformin in plasma and urine using ion-pair extraction techniques.

Authors:  J Keal; A Somogyi
Journal:  J Chromatogr       Date:  1986-06-13

3.  Pharmacokinetics of metformin after intravenous and oral administration to man.

Authors:  P J Pentikäinen; P J Neuvonen; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

4.  Creatinine XII: comparison of assays of low serum creatinine levels using high-performance liquid chromatography and two picrate methods.

Authors:  Y C Huang; W L Chiou
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

5.  Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.

Authors:  J van Crugten; F Bochner; J Keal; A Somogyi
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

6.  Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.

Authors:  A Somogyi; A McLean; B Heinzow
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Metformin associated lactic acidosis.

Authors:  P J Phillips; R Scicchitano; A R Clarkson; H R Gilmore
Journal:  Aust N Z J Med       Date:  1978-06

8.  Disposition of metformin (N,N-dimethylbiguanide) in man.

Authors:  C R Sirtori; G Franceschini; M Galli-Kienle; G Cighetti; G Galli; A Bondioli; F Conti
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

9.  Probenecid: an unexplained effect on cephalosporin pharmacology.

Authors:  P G Welling; S Dean; A Selen; M J Kendall; R Wise
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

10.  Cimetidine inhibits renal procainamide clearance.

Authors:  C D Christian; C G Meredith; K V Speeg
Journal:  Clin Pharmacol Ther       Date:  1984-08       Impact factor: 6.875

View more
  71 in total

Review 1.  Metformin pathways: pharmacokinetics and pharmacodynamics.

Authors:  Li Gong; Srijib Goswami; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-11       Impact factor: 2.089

Review 2.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

3.  Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).

Authors:  Mark J Dresser; Guangqing Xiao; Maya K Leabman; Andrew T Gray; Kathleen M Giacomini
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

4.  Cimetidine does not appear to influence the distribution of metformin into human milk.

Authors:  Sharon J Gardiner; Carl M J Kirkpatrick; Mei Zhang; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2008-06-09       Impact factor: 4.335

5.  Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.

Authors:  Philip J Sandoval; Kimberley M Zorn; Alex M Clark; Sean Ekins; Stephen H Wright
Journal:  Mol Pharmacol       Date:  2018-06-08       Impact factor: 4.436

6.  The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects.

Authors:  Yi Ding; YanYan Jia; Ying Song; ChengTao Lu; YuWen Li; MinChun Chen; MingMing Wang; AiDong Wen
Journal:  Eur J Clin Pharmacol       Date:  2013-10-30       Impact factor: 2.953

Review 7.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 8.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 9.  A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.

Authors:  Hélène M Faessel; R Scott Obach; Hans Rollema; Patanjali Ravva; Kathryn E Williams; Aaron H Burstein
Journal:  Clin Pharmacokinet       Date:  2010-12       Impact factor: 6.447

Review 10.  Renal effects of peptic ulcer therapy.

Authors:  E Burgess; D Muruve
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.